Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Tim Levine
UCL Institute of Ophthalmology
11-43 Bath St
Prof Tim Levine profile picture
  • Professor of Cell Biology
  • Institute of Ophthalmology
  • Faculty of Brain Sciences

Research Summary

We mostly work on the broad biological question of how lipids and proteins interact inside cells, using budding yeast, a genetically tractable model system. Understanding lipid metabolism is of great medical importance for diseases prevalent in the Western world, including important ophthalmic diseases (such as Age-related macular degeneration), major brain disorders (Alzheimer's and Parkinson's), and also atherosclerosis and cardiovascular disease. Many important aspects of intracellular lipid metabolism are conserved between humans and yeast, so that new understanding gained in the single celled organism is highly relevant for eukaryotes in general.

This work focuses on lipid traffic across narrow cytoplasmic gaps where organelles come very close to each other. These membrane contact sites are very poorly understood because they are put together by multiple bridging complexes, and the routes of traffic are circular. Therefore, the traditional genetic approach of finding mutants that lack lipid traffic has often failed for membrane contact sites. Instead, we rely on a candidate approach, using bioinformatics tools to predict which proteins are likely to be involved.

Our first major discovery in this field was that VAP, a conserved endoplasmic reticulum protein, binds to a large variety of proteins by picking out a short stretch of primary sequence we named the FFAT motif that we found using PROSITE. This was initially found in proteins that transfer lipids between organelles, but has since been found to be the only way for cytoplasmic proteins to access the endoplasmic reticulum. Binding to VAP allows lipid transfer proteins to form bridges between the endoplasmic reticulum (where most lipids are made) and other organelles to which lipid is transferred.

From this we moved to discover and study a brand new family of lipid transfer proteins which are anchored at membrane contact sites. We identified this family with the structural bioinformatics tool HHsearch. This tool has been highly useful in the lab as a fast and accurate way to identify remote homology between proteins that share almost no identifiable sequence. The tool allows us to find which proteins share the same fold, so are likely to have evolved from a common ancestor.

Evolving from our specific use of this tool to make advances in lipid traffic at contact sites, we have made other bioinformatic discoveries, for example identifying the translated product of the C9ORF72 gene as DENN-like. We have bench-marked the likely extent of new prediction and discovery by HHsearch genome-wide. In yeast it may reduce unknown regions by one third (from current level of 15% of ORFs to 10%). To disseminate this knowledge, we have teamed up with the UCL Department of Computer Science to create a S. cerevisiae whole-genome HHsearch database, which will go live in 2017. It will be formatted to be compatible with the Saccharomyces Genome Database (SGD) for publication alongside the current Interpro dataset.

Antifungal research: I have a long-standing collaboration with F2G Ltd (Eccles, near Manchester), a biotech company dedicated to developing new anti-fungal drugs. So far we worked on two projects linking possible new anti-fungal targets to the biology of fungi - both S. cerevisiae and pathogenic species such as A. fumigatus. From 2020 onwards, we will collaborate on an anti-fungal target that is moving beyond the "potential" stage into being a reality: Olorofim, the first member of a new class of drugs - the orotomides. While it is being tested in Phase IIb clinical trials, and is known to be fungicidal by inhibiting a conserved enzyme, the mechanism off cidality is still unknown. Finding out more on this will increase the value of the entire class of compounds in terms of developing them for wider use to help society. 
Teaching Summary


Cell Biology lectures in Year 2 and Year 3

University life outside research

I am active in the department's Equality Challenge Team, joining in 2016 and becoming co-chair in 2017.  I am also co-chair of the UCL Athena Forum, which brings together all UCL departments' Athena and Equality/Diversity/Inclusion (EDI) teams. 

In March 2020, I became the Institute of Ophthalmology's Deputy Director for EDI, a new role that cements the department's vision to work on moving towards genuine equality for all students and staff.

01-OCT-2018 Professor in Cell Biology    , United Kingdom
Academic Background
1993   Doctor of Philosophy University College London
1986   Bachelor of Medicine/Bachelor of Surgery University College London
1983   Bachelor of Arts University of Cambridge
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by